author-photo

Luca Malorni

University of Naples Federico II

78

Papers

1234

Citations

Citation Trend

Filter By

Papers (62) Sort By

Journal Conference Others

8P Mutational analysis of circulating tumour DNA (ctDNA) in patients with ER+/HER2- advanced breast cancer (ABC) receiving palbociclib (P): Results from the TREnd trial

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Exploring Serum NMR-Based Metabolomic Fingerprint of Colorectal Cancer Patients: Effects of Surgery and Possible Associations with Cancer Relapse

2021 Applied Sciences
Show All
- Source
- Cite
- Save
Citations (0)
Activation of the interferon signaling pathway is associated with resistance to CDK4/6 inhibitors and immune checkpoint activation in ER-positive breast cancer.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)
Precision Oncology via NMR-Based Metabolomics: A Review on Breast Cancer.

2021 International Journal of Molecular Sciences
Show All
- Source
- Cite
- Save
Citations (3)
292P Serum thymidine kinase 1 activity in patients with hormone receptor positive (HR+)/HER2 negative (HER2-) advanced breast cancer (aBC) treated in first-line with ribociclib (R) and letrozole (L) in the BioItaLEE trial

2021 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (0)
?Bridge? neoadjuvant endocrinetherapy for early stage breast cancer patients during COVID-19 at an academic hospital in NYC: Lessonslearned

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Abstract OT-28-02: Phase II randomized trial of neoadjuvant trastuzumab and pertuzumab with either palbociclib plus letrozole or paclitaxel for postmenopausal women with estrogen receptor-positive / HER2-positive breast cancer - The TOUCH trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Charting differentially methylated regions in cancer with Rocker-meth.

2021
Show All
- Source
- Cite
- Save
Citations (0)
Abstract P4-04-07: A DNA-methylation signature to predict resistance to the CDK4/6 inhibitor palbociclib

2020 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Cdk4/6 inhibitors: a focus on biomarkers of response and post-treatment therapeutic strategies in hormone receptor-positive her2-negative breast cancer

2020 Cancer Treatment Reviews
Show All
- Source
- Cite
- Save
Citations (5)